Outcome of poor prognostic phenotype non-Hodgkin lymphoma treatment among HIV-positive patients compared with HIV-negative counterparts in the HAART era: Experience from Hurlingham Oncology Clinic, ...

frontMIND randomized 899 IPI 3–5 DLBCL/HGBL patients to six 21-day cycles of tafa-len-R-CHOP versus R-CHOP across 298 global centers. Progression-free survival improved (HR 0.75; P=.019) with ...

Please provide your email address to receive an email when new articles are posted on . The regimen conferred a 71% complete response rate among older adults with newly diagnosed DLBCL. Median PFS and ...

Association of liposomal pegylated doxorubicine, fludarabine and cyclophosphamide as first line treatment in disseminated small B-cell lymphoma in adult patients ...